Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Russia, Ukraine Sanctions Put Onus on Checking Ownership (<i>The Wall Street Journal Risk & Compliance Journal</i>)

Russia, Ukraine Sanctions Put Onus on Checking Ownership (The Wall Street Journal Risk & Compliance Journal)

Related Content

The 2026 National Defense Strategy Signals Increased DIB Contracting and Investment Opportunities

Final FY 2026 NDAA Includes BIOSECURE Provisions and New Opportunities for Biotech as DoD National Security Priority

The Supreme Court Considers Presidential Authority

BIOSECURE Act Included in Final Draft NDAA Compromise Text

Not Guilty (Yet): The Export-Related Affiliates Rule Is Postponed by One Year

Crude Awakening: United States Sanctions Rosneft and Lukoil

BIOSECURE Included in Draft National Defense Authorization Act of 2026

Happy 90th Birthday, ITAR!

Flow Neuroscience Announces FDA Approval of World’s First At-Home Brain Stimulation Treatment for Depression

Goodwin Advises SciNeuro in Entering into a Licensing and Collaboration Agreement with Novartis for $165 Million Upfront and Up to $1.5 Billion in Milestones

Best Law Firms 2026 Names Goodwin ERISA Litigation Law Firm of the Year and Recognizes 50 Practice Areas

The Legal 500 US 2025 Recognizes 44 Goodwin Practices and 172 Lawyers

Chambers USA 2025 Recognizes a Record Number of Goodwin Practices and Lawyers for Exceptional Client Service

SpringWorks Therapeutics To Be Acquired By Merck KGaA, Darmstadt, Germany For $3.9 Billion

Chambers Global 2025 Recognizes Goodwin Lawyers and Practices as Worldwide Leaders

Novo Holdings Completes $16.5 Billion Acquisition of Catalent

Global Trade